TLSA
Income statement / Annual
Last year (2023), Tiziana Life Sciences Ltd's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Tiziana Life Sciences Ltd's net income was -$17.69 M.
See Tiziana Life Sciences Ltd,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$8.11 M
|
$12.96 M
|
$13.21 M
|
$5.99 M
|
$2.91 M
|
$4.34 M
|
$4.67 M
|
$2.96 M
|
$6.29 M
|
$794,000.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$855,000.00
|
$13.21 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$0.00
|
$0.00
|
$855,000.00
|
$13.21 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Other Expenses |
$9.87 M
|
$1.63 M
|
$13.31 M
|
$8.82 M
|
$4.86 M
|
$3.48 M
|
$3.57 M
|
$4.33 M
|
$2.33 M
|
$1.97 M
|
| Operating Expenses |
$17.98 M
|
$14.59 M
|
$27.37 M
|
$30.04 M
|
$7.77 M
|
$7.82 M
|
$8.25 M
|
$7.29 M
|
$8.61 M
|
$2.76 M
|
| Cost And Expenses |
$17.98 M
|
$14.59 M
|
$27.37 M
|
$28.03 M
|
$7.77 M
|
$7.82 M
|
$8.25 M
|
$7.29 M
|
$8.61 M
|
$2.76 M
|
| Interest Income |
$1.15 M
|
$0.00
|
$0.00
|
$8,000.00
|
$1,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$10,000.00
|
$7,000.00
|
$176,000.00
|
$320,000.00
|
$73,000.00
|
$9,456.96
|
$9,000.00
|
$9,000.00
|
$18,000.00
|
$14,000.00
|
| Depreciation & Amortization |
$96,000.00
|
$51,000.00
|
$141,000.00
|
$89,764.00
|
$198,000.00
|
$12,609.00
|
$11,000.00
|
$8,000.00
|
$0.00
|
-$794,000.00
|
| EBITDA |
-$17.14 M |
-$15.34 M |
-$26.34 M |
-$27.93 M |
-$7.58 M |
-$7.81 M |
-$8.24 M |
-$7.28 M |
-$8.61 M |
-$3.56 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$742,000.00
|
-$811,000.00
|
$717,000.00
|
-$312,000.00
|
-$73,000.00
|
-$8,668.88
|
-$9,000.00
|
-$9,000.00
|
-$18,000.00
|
-$808,000.00
|
| Income Before Tax |
-$17.24 M
|
-$15.40 M
|
-$26.66 M
|
-$28.34 M
|
-$7.85 M
|
-$7.83 M
|
-$8.26 M
|
-$7.30 M
|
-$8.63 M
|
-$3.57 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$449,000.00
|
$0.00
|
-$3.24 M
|
-$2.21 M
|
-$540,000.00
|
-$1.53 M
|
-$1.49 M
|
-$89,000.00
|
$0.00
|
-$60,000.00
|
| Net Income |
-$17.69 M
|
-$15.40 M
|
-$23.42 M
|
-$26.13 M
|
-$7.31 M
|
-$6.30 M
|
-$6.77 M
|
-$7.21 M
|
-$8.63 M
|
-$3.51 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
0 |
-0.15 |
-0.24 |
-0.27 |
-0.0535 |
-0.0988 |
-0.13 |
-0.15 |
-0.19 |
-0.31 |
| EPS Diluted |
0 |
-0.15 |
-0.24 |
-0.27 |
-0.0535 |
-0.0988 |
-0.13 |
-0.15 |
-0.19 |
-0.31 |
| Weighted Average Shares Out |
$0.00
|
$101.53 M
|
$97.93 M
|
$97.31 M
|
$136.48 M
|
$63.78 M
|
$53.20 M
|
$46.80 M
|
$45.62 M
|
$11.43 M
|
| Weighted Average Shares Out Diluted |
$0.00
|
$101.53 M
|
$97.93 M
|
$97.31 M
|
$136.48 M
|
$63.78 M
|
$53.20 M
|
$46.80 M
|
$45.62 M
|
$11.43 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
